-
2002
Sinocare was established
-
2004
Launched the first SXT-1 blood glucose meter, and developed test strips with automatic capillary action for sample collection
-
2007
Engaged in China-Cuba biotechnology cooperation and realized large-scale export to Cuba and Latin American markets
-
2012
Sinocare went public on SZSE (Shenzhen Stock Exchange), the first listed company of blood glucose meter in China
-
2015
Developed China’s first truly hospital-grade blood glucose meter: Gold-Accu
-
2016
Acquisition of largest US based BGM manufacturer Nipro Diagnostic Inc.(Now renamed as Trividia Health Inc.) and PTS Diagnostics Inc.
-
2017
Sinocare Hospital diabetes management system was implemented
-
2019
AGEscan, a non-invasive diabetes risk screening product, opening a new entrance to the whole course management of diabetes
-
2020
iPOCT standardization laboratory is marketed officially in CMEF Shanghai
-
2022
Sinocare Qingshan Park - the new iPOCT industrial park was put into use
-
2023
The Continuous Glucose Monitoring (CGMS) product-Sinocare iCan officially obtained the product registration certificate